BIRAC

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

Retrieved on: 
Wednesday, February 22, 2023
Tobacco Products Scientific Advisory Committee, Department of Biotechnology, Cancer, National academy, Woman, DBT, Organization, NASI, Public sector, Joint FAO/WHO Expert Committee on Food Additives, Patient, BIRAC, SME, Ministry, AMR, Public, Developing country, National Science Advisory Board for Biosecurity, Infection, Organization for Women in Science for the Developing World, National Biotechnology Research Park, COVID-19, Advisory board, Pharmaceutical industry, Biotechnology, Science

BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department of Biotechnology, Government of India and brings in more than three decades of experience in the biotech sector. 

Key Points: 
  • Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research
    BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board.
  • Speaking on her appointment, Dr. Anand Anandkumar - CEO, Bugworks Research states, "Bugworks is pleased to welcome Dr. Renu Swarup as a member of its Global Advisory Board.
  • We look forward to working closely with Dr. Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products."
  • On joining Bugworks Research, Dr. Renu Swarup said, "I am pleased to be associated with Bugworks in my capacity as an Honorary Advisor and member of their Global Advisory Board.

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

Retrieved on: 
Wednesday, February 22, 2023
Tobacco Products Scientific Advisory Committee, Department of Biotechnology, Cancer, National academy, Woman, DBT, Organization, NASI, Public sector, Joint FAO/WHO Expert Committee on Food Additives, Patient, BIRAC, SME, Ministry, AMR, Public, Developing country, National Science Advisory Board for Biosecurity, Infection, Organization for Women in Science for the Developing World, National Biotechnology Research Park, COVID-19, Advisory board, Pharmaceutical industry, Biotechnology, Science

BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department of Biotechnology, Government of India and brings in more than three decades of experience in the biotech sector. 

Key Points: 
  • Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research
    BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/ -- Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board.
  • Speaking on her appointment, Dr. Anand Anandkumar - CEO, Bugworks Research states, "Bugworks is pleased to welcome Dr. Renu Swarup as a member of its Global Advisory Board.
  • We look forward to working closely with Dr. Swarup to help us reach our goal of enabling equitable global access to Bugworks' innovative products."
  • On joining Bugworks Research, Dr. Renu Swarup said, "I am pleased to be associated with Bugworks in my capacity as an Honorary Advisor and member of their Global Advisory Board.

Global Bioinformatics Market Analysis 2022-2026: A $21.32 Billion Market in 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 15, 2022
Software, Research, Hardware, Data Management, Technology, Genetics, Science, Chemicals, Plastics, Biotechnology, Manufacturing, Other Science, Health, Sequence, Protein, Department of Biotechnology, Nanopore, DNA, Matrix, Adoption, BIRAC, Biotechnology, TRL, User (computing), Nanopore sequencing, UniProt, Biotechnology Industry Research Assistance Council, Research, Database, Collection, Compliance, Department, Government of India, Growth, Technology, Application, ORC, DBT, Oxford Nanopore Technologies, Avro, Polymerase, Polymerase chain reaction, Parquetry, Biotechnology industry in China, CRS, Co-production (public services), Organic acid, Fine chemical

The "Bioinformatics Global Market Report 2022, By Products and Services, By Application, By End Users" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bioinformatics Global Market Report 2022, By Products and Services, By Application, By End Users" report has been added to ResearchAndMarkets.com's offering.
  • Lack of interoperability among various available data formats is acting as a restraint on the bioinformatics market.
  • The bioinformatics market is governed by various regulatory bodies for quality and compliance of bioinformatics platforms.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Bioinformatics Global Market Research Report 2021 Featuring Agilent Technologies, Illumina, QIAGEN, Affymetrix and Thermo Fisher Scientific - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 21, 2021
Data Management, Health, Technology, Software, Pharmaceutical, Biotechnology, Sequence, Agilent Technologies, DNA, Biotechnology industry in China, Program, Adoption, Growth, Technology, QIAGEN, Drug discovery, Data analysis, Compliance, Mathematics, TRL, UniProt, Nanopore, Affymetrix, Polymerase chain reaction, Polymerase, DBT, Protein, Database, Collection, Department of Biotechnology, Matrix, COVID-19, Nanopore sequencing, Parquetry, Biotechnology Industry Research Assistance Council, Biotechnology, Department, BIRAC, ORC, Organic acid, Research, Government of India, Avro, Thermo Fisher Scientific, CRS, Information technology, Fine chemical, Illumina

The "Bioinformatics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Bioinformatics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and Thermo Fisher Scientific.
  • Lack of interoperability among various available data formats is acting as a restraint on the bioinformatics market.
  • Companies in the bioinformatics market are increasingly investing in the research and development of nanopore sequencing technology.

Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world

Retrieved on: 
Friday, August 20, 2021
National Institute of Virology, Population, Plasmid, Drugs Controller General of India, Immune system, Phase, DNA, DCGI, Indian Council of Medical Research, Disease, Cadila Healthcare, EUA, Adult, Volunteering, Immunity, Immunization, BIRAC, Emergency Use Authorization, COVID-19, Department, National Institute, Medical research, Vaccine, Pharmaceutical industry

ZyCoV-D is a three dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.

Key Points: 
  • ZyCoV-D is a three dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.
  • With this approval, India now has its first COVID-19 vaccine for the adolescents in the 12-18 age group, besides the adult population.
  • ZyCoV-D, is a needle-free vaccine administered using The PharmaJet a needle free applicator, which ensures painless intradermal vaccine delivery.
  • This is for the first time that a technologically advanced vaccine has been successfully developed on the Plasmid DNA platform for human use.